Daraxonrasib, a new pancreatic cancer drug, cut the risk of death by 60% in a Phase 3 trial. A doctor explains how it works, side effects and when it could reach patients.
Behind the viral Rise plushie from NASA’s Artemis II mission is a bigger story: the freelancers who made it happen, and how they’re making money and shaping the future.
Not sure what today’s NYT Connections answers are all about? Find out just what the different words in today’s grid mean and how they fit together.
Stanford’s 2026 AI Index: agents approach human performance, $582B invested, entry-level jobs vanish. The technology is ready. The organizations deploying it are not.
Serially cloned mice hit a genetic “dead end” by generation 58, underscoring that sex evolved for variation, purging harmful mutations and keeping lineages viable.
Amazon is making its most aggressive move yet to close the gap with SpaceX to shortcut its way into becoming a cell service provider.
This innovative collar-clip gadget is being launched on Kickstarter and it’s designed to bridge the linguistic gap between humans and their cats and dogs.
Distribution moat startup VC 2026: how AI collapsing software costs has made audience-building and go-to-market strategy the primary defensibility signal for venture-backed founders, and why marketing roles are gaining status and engineering-style tit…
Stanford’s 2026 AI Index shows a mixed picture on AI data, jobs, and productivity.
There are rumors that Xbox is planning to dramatically rethink its position on exclusive games after sending so many to PlayStation.